Coverage
-
September 13, 2023
Health care industry supplier Cardinal Health Inc. and certain of its investors got final approval Wednesday for their $109 million deal to end claims that Cardinal acquired a Johnson & Johnson unit without disclosing inventory and supply chain issues its acquisition target faced.
1 other articles on this case.
View all »